Owl Creek Asset Management’s Jasper Therapeutics JSPR Stock Holding History

Owl Creek Asset Management’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-14,900	Closed	-$1.48M	–	432
2021 Q2	$1.48M	Hold	14,900	–	–	0.07%	116
2021 Q1	$1.48M	Buy	+14,900	New	+$1.52M	0.05%	98
2020 Q3	–	Sell	-86,100	Closed	-$8.82M	–	114
2020 Q2	$8.82M	Hold	86,100	–	–	0.67%	18
2020 Q1	$8.18M	Buy	+86,100	New	+$8.42M	0.65%	19

Other funds holding JSPR

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPARFS

Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54K AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Owl Creek Asset Management's JSPR Position: Q3 2021 in Review

Owl Creek Asset Management sold out of Jasper Therapeutics (JSPR) in Q3 2021, closing a stake of 14,900 shares — an estimated $1.48M sold.

Owl Creek Asset Management first reported a position in JSPR in Q1 2020 and held it in 4 quarters. The position peaked at $8.82M in Q2 2020. 10 funds tracked by Wall St. Rank hold JSPR as of Q3 2021.

Owl Creek Asset Management reported no remaining Jasper Therapeutics position as of Q3 2021 after selling out during the quarter.
Owl Creek Asset Management sold 14,900 Jasper Therapeutics shares in Q3 2021, an estimated $1.48M.
Owl Creek Asset Management first reported a position in Jasper Therapeutics in Q1 2020 and held it in 4 quarters.
Owl Creek Asset Management's Jasper Therapeutics position peaked at $8.82M in Q2 2020.
10 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2021.

Based on Owl Creek Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.